Daiken Medical Co., Ltd.

TSE:7775 Voorraadrapport

Marktkapitalisatie: JP¥14.4b

Daiken Medical Toekomstige groei

Future criteriumcontroles 3/6

Daiken Medical is forecast to grow earnings and revenue by 14.5% and 7.9% per annum respectively. EPS is expected to grow by 13.1% per annum. Return on equity is forecast to be 17.6% in 3 years.

Belangrijke informatie

14.5%

Groei van de winst

13.1%

Groei van de winst per aandeel

Medical Equipment winstgroei13.7%
Inkomstengroei7.9%
Toekomstig rendement op eigen vermogen17.6%
Dekking van analisten

Low

Laatst bijgewerkt06 Sep 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

TSE:7775 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (JPY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
3/31/202711,9001,4851,0101,6492
3/31/202611,0001,3009401,4822
3/31/202510,1001,0909711,3082
9/30/20249,8401,0591,2921,426N/A
6/30/20249,7841,033N/AN/AN/A
3/31/20249,7509881,3871,555N/A
12/31/20239,647912N/AN/AN/A
9/30/20239,5078201,0381,243N/A
6/30/20239,302754N/AN/AN/A
3/31/20239,137712790989N/A
12/31/20229,016857N/AN/AN/A
9/30/20228,9088607811,008N/A
6/30/20228,759857N/AN/AN/A
3/31/20228,5408319311,133N/A
12/31/20218,266705N/AN/AN/A
9/30/20218,176725705864N/A
6/30/20218,048715N/AN/AN/A
3/31/20217,861675297609N/A
12/31/20208,038797N/AN/AN/A
9/30/20208,0467958491,137N/A
6/30/20208,256763N/AN/AN/A
3/31/20208,5238591,2671,436N/A
12/31/20198,416772N/AN/AN/A
9/30/20198,4597808861,108N/A
6/30/20198,373828N/AN/AN/A
3/31/20198,406851673880N/A
12/31/20188,458970N/AN/AN/A
9/30/20188,5469868251,014N/A
6/30/20188,5901,031N/AN/AN/A
3/31/20188,5851,012N/A1,255N/A
12/31/20178,6511,071N/AN/AN/A
9/30/20178,4531,131N/A1,297N/A
6/30/20178,4531,188N/AN/AN/A
3/31/20178,3991,246N/A1,350N/A
12/31/20168,4291,210N/AN/AN/A
9/30/20168,4061,196N/A1,402N/A
6/30/20168,3281,156N/AN/AN/A
3/31/20168,2611,153N/A1,294N/A
12/31/20158,1781,175N/AN/AN/A
9/30/20158,1151,159N/A1,335N/A
6/30/20158,1141,150N/AN/AN/A
3/31/20158,0331,097N/A1,140N/A
12/31/20147,9601,007N/AN/AN/A
9/30/20147,905966N/A871N/A
6/30/20147,748921N/AN/AN/A
3/31/20147,635881N/A995N/A
12/31/20137,465887N/AN/AN/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 7775's forecast earnings growth (14.5% per year) is above the savings rate (0.3%).

Winst versus markt: 7775's earnings (14.5% per year) are forecast to grow faster than the JP market (8.9% per year).

Hoge groeiwinsten: 7775's earnings are forecast to grow, but not significantly.

Omzet versus markt: 7775's revenue (7.9% per year) is forecast to grow faster than the JP market (4.2% per year).

Hoge groei-inkomsten: 7775's revenue (7.9% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 7775's Return on Equity is forecast to be low in 3 years time (17.6%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y